← Eichor
Condition: Non Hodgkin S Lymphoma Disorder Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Non Hodgkin S Lymphoma Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The "Let's Talk Tech" Tool to Support Decision Making About Technology Use
NA · 1 location(s) · University of Washington · NCT06817122Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT05724121A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refract
Phase 1/Phase 2 · 22 location(s) · AstraZeneca · NCT07123454Natural History of KSHV-Associated Multicentric Castleman s Disease
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT04968288Registry of Older Patients With Cancer
Phase N/A · 7 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137825Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)
Phase 2/Phase 3 · 3 location(s) · Monash University · NCT07202091Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Phase 3 · 65 location(s) · Novartis Pharmaceuticals · NCT06784752Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL
NA · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07059741Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies
Phase N/A · 1 location(s) · University Hospital, Angers · NCT071476213'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Phase N/A · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT00935090Evaluation of Skin Tests in Biotherapy Allergies
NA · 1 location(s) · University Hospital, Angers · NCT06971848AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Phase 1/Phase 2 · 37 location(s) · AstraZeneca · NCT06137144Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137643Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)
Phase 2/Phase 3 · 3 location(s) · Monash University · NCT07202078Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)
Phase 2/Phase 3 · 3 location(s) · Monash University · NCT07202065Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Phase 1/Phase 2 · 26 location(s) · AstraZeneca · NCT07109219A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated
Phase 1/Phase 2 · 17 location(s) · BeOne Medicines · NCT06697184A Study of GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies
Phase 1/Phase 2 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06066203
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.